REQUEST A DEMO
Total
USD $0.00
Search more companies

Croient Pharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Croient Pharma Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Croient Pharma Private Limited is based in India, with the head office in Thane. The company operates in the Pharmaceutical and Medicine Manufacturing sector. It was established on February 14, 2012. In its most recent financial highlights, the company reported a net sales revenue increase of 74.51% in 2024. Its’ total assets recorded a growth of 45.63%. The net profit margin of Croient Pharma Private Limited decreased by 0.24% in 2024.

Legal Address
Shop No. 2, Srushti Society, Kolbad Road, Thane (West)
Thane; Maharashtra; Postal Code: 400601

Contact Details: Purchase the Croient Pharma Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Croient Pharma Private Limited report to view the information.
Financial Auditors:
Purchase the Croient Pharma Private Limited report to view the information.
Incorporation Date:
February 14, 2012
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Croient Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
74.51%
Total Operating Revenue
75.69%
Operating Profit
96.52%
EBITDA
96.17%
Net Profit/Loss for the Period
69.38%
Total Assets
45.63%
Total Equity
39.2%
Operating Profit Margin
1.59%
Net Profit Margin
-0.24%
Return on Equity (ROE)
5.02%
Debt / Equity
-11.37%
Quick Ratio
0.4%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?